ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

Bypass Budget For FY Seeks $1.189 Billion, Would Fund 1,018 Competing Grants, Restore Cuts

May 20, 1983

NIH Investigation Clear Gallo Of Charge He Stole Aids Virus

October 12, 1990

DCT Board Approves Recompetition Of Drug Development Contracts

June 25, 1993

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980

Alan Rabson Named NCI Deputy Director

August 11, 1995

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011